Antibodies
5 December 2013
European Medicines Agency Approves Once Every Two Weeks Dosing Option For Hizentra®▼ (Human Normal Immunoglobulin, SCIg)5 December 2013
Apogenix’ APG350 Effectively Induces Apoptosis of Tumor Cells via TRAIL Pathway Independent of Fc-gamma Cross-Linking28 November 2013
Bayer Submits VEGF Trap-Eye (aflibercept solution for injection) for the Treatment of Myopic Choroidal Neovascularization in Japan26 November 2013
Merrimack Pharmaceuticals’ MM-121 Demonstrates Positive Signal in Two Phase 2 ER/PR+ Breast Cancer Studies25 November 2013
Glycotope Doses First Patients in Phase IIb Study with PankoMab-GEX(TM) for the Maintenance Therapy of Ovarian Carcinoma22 November 2013
Merck announces CHMP Positive Opinion to Update Erbitux Metastatic Colorectal Cancer Labeling to Patients with RAS Wild-type Tumors22 November 2013
EYLEA® (aflibercept) Injection Approved For The Treatment of Macular Edema Following Central Retinal Vein Occlusion In Japan22 November 2013
Sanofi and Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration Trial20 November 2013
Omni Bio Announces Reduction in Inflammatory Myocardial Injury With Its Lead Recombinant Molecule20 November 2013
Amgen Announces Evolocumab (AMG 145) Results From First 52-Week Study Of A PCSK9 Inhibitor To Reduce LDL Cholesterol18 November 2013
Actinium Pharmaceuticals Announces Plans For Iomab™-B Phase 3 Pivotal Trial Following Meeting With FDA16 November 2013
Roche presents lampalizumab biomarker data from phase II study in advanced form of dry macular degeneration14 November 2013
Sorrento Enters into Definitive Agreement to Acquire Antibody Drug Conjugation Technology11 November 2013
ImmunoGen, Inc. Announces Fifth New License Agreement in 2013News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports